Gain Therapeutics, Inc.
GANXBiotechnology
$1.19−0.42%As of Oct 29vs prior close
- Market cap
- $51.9M
- P/E (TTM)
- –
- From 52W high
- −71.53%
- EPS (LTM)
- -$0.50
- Revenue (YE23)
- $55.2K
- Dividend yield
- 0.00%
Nomior Score
33
Steady ProfileSpeculativeBottom 19% of the scored universe
Growth—
Quality32
Value—
Momentum40
Resilience34
Growth
+24.09%revenue a year over 3 fiscal years
YE20 $28.9KYE23 $55.2K
Connections
Revenue to profitYE23
The operating loss was 40328% of revenue, wider by 27640 pts on a year.
Who owns it
1tracked portfolio